PRIMARY PULMONARY NON-HODGKIN’S LYMPHOMA

Authors

  • I. V. Zhulkevich SHEI Ternopil State Medical University by I. Ya. Horbachevsky
  • T. Yu. Uglyar SHEI Ternopil State Medical University by I. Ya. Horbachevsky
  • N. V. Deresh SHEI Ternopil State Medical University by I. Ya. Horbachevsky

DOI:

https://doi.org/10.11603/2415-8798.2015.2.5629

Abstract

Pulmonary non-Hodgkin’s lymphoma is a very rare tumor, which comprises only 0.5 % of all malignancies of lungs. Recommended treatment options include complete surgical excision, surgery followed by radiotherapy or chemotherapy alone but, the optimal therapy remains unclear. The article presents the results of treatment of the patient with primary pulmonary lymphoma, who achieved a partial response after four courses of R-CHOP chemotherapy.

References

A case of bronchus-associated lymphoid tissue (BALT) lymphoma treated with lobectomy / W. S. Choi, J. H. Cho, Y. I. Hwang [et al.] // Tuberc. Respir. Dis. 2007. – Vol. 62. – P. 427–431.

Radiation therapy for bronchial associated lymphoid tissue (BALT) lymphoma: a case report / S. Y. Song, E. K. Choi, J. H. Kim [et al.] // J. Lung Cancer. – 2006. – Vol. 5. – P. 114–117.

Extended rituximab schedules may result in increased efficacy in pulmonary malt lymphoma / M. Seker, A. Bilici, B. O. Ustaalioglu [et al.] // Leuk. Res. – 2009. – Vol. 33. – P. 154–156.

Mucosa associated lymphoid tissue lymphoma of the lung: the Royal Marsden Hospital experience / H. T. Arkenau, C. Gordon, D. Cunningham [et al.] // Leuk. Lymphoma. – 2007. – Vol. 48. – P. 547–550.

Eight-cycle rituximab therapy resulted in complete remission in primary cutaneous marginal zone lymphoma / M. Seker, B. B. Ustaalioğlu, A. Bilici [et al.] // Leuk. Res. – 2010. – Vol. 34. – P. 160–163.

Published

2015-05-09

How to Cite

Zhulkevich, I. V., Uglyar, T. Y., & Deresh, N. V. (2015). PRIMARY PULMONARY NON-HODGKIN’S LYMPHOMA. Bulletin of Scientific Research, (2). https://doi.org/10.11603/2415-8798.2015.2.5629

Issue

Section

EXCHANGE OF EXPERIENCE